JP Stock MarketDetailed Quotes

Takeda Pharmaceutical (4502)

Watchlist
  • 5239.0
  • -31.0-0.59%
20min DelayMarket Closed May 1 15:30 JST
8.34TMarket Cap77.93P/E (Static)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Takeda Pharmaceutical (4502) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Dec 31, 2025
(Q2)Sep 30, 2025
(Q1)Jun 30, 2025
(FY)Mar 31, 2025
(Q4)Mar 31, 2025
(Q3)Dec 31, 2024
(Q2)Sep 30, 2024
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
Total revenue
4.16%1.19T
-5.38%1.11T
-8.39%1.11T
7.45%4.58T
0.24%1.05T
2.96%1.14T
12.75%1.18T
14.11%1.21T
5.87%4.26T
9.91%1.05T
Operating revenue
4.16%1.19T
-5.38%1.11T
-8.39%1.11T
7.45%4.58T
0.24%1.05T
2.96%1.14T
12.75%1.18T
14.11%1.21T
5.87%4.26T
9.91%1.05T
Cost of revenue
-3.77%401.15B
-3.61%380.06B
-0.59%384.68B
10.76%1.58T
-0.11%382.08B
9.85%416.87B
14.76%394.31B
20.50%386.95B
14.68%1.43T
23.48%382.5B
Gross profit
8.70%790.55B
-6.27%732.74B
-12.06%722.01B
5.79%3T
0.44%671.32B
-0.61%727.25B
11.75%781.73B
11.33%821.04B
1.93%2.84T
3.40%668.37B
Operating expense
-5.84%621.73B
11.09%663.74B
-17.91%537.45B
1.80%2.52T
14.52%602.78B
-16.71%660.31B
-20.21%597.48B
15.08%654.71B
12.54%2.47T
14.30%526.35B
Selling and administrative expenses
4.51%282.78B
-5.49%253.55B
-5.24%255.89B
4.83%1.1T
3.73%295.87B
1.15%270.59B
6.06%268.28B
8.83%270.03B
5.67%1.05T
11.95%285.23B
Research and development costs
2.96%175.23B
-8.02%161.48B
-14.59%143.89B
0.04%730.23B
10.29%216.01B
-9.17%170.19B
-4.56%175.56B
3.52%168.46B
15.25%729.92B
21.69%195.86B
Depreciation amortization depletion
5.19%141.91B
44.06%205.16B
-19.16%131.64B
-1.36%643.23B
39.94%203.08B
-46.69%134.91B
-40.72%142.41B
25.81%162.83B
20.22%652.12B
8.92%145.11B
-Depreciation and amortization
5.19%141.91B
44.06%205.16B
-19.16%131.64B
-1.36%643.23B
39.94%203.08B
-46.69%134.91B
-40.72%142.41B
25.81%162.83B
20.22%652.12B
8.92%145.11B
Other operating expenses
-74.24%21.8B
288.16%43.55B
-88.70%6.03B
5.67%37.05B
-12.33%-112.17B
-0.22%84.61B
-84.35%11.22B
86.29%53.38B
55.70%35.06B
-12.90%-99.86B
Operating profit
152.19%168.82B
-62.55%69B
10.96%184.57B
32.74%486.06B
-51.74%68.54B
209.60%66.94B
473.41%184.25B
-1.33%166.33B
-37.71%366.17B
-23.59%142.02B
Net non-operating interest income /expenses
7.33%-35.76B
39.78%-38.74B
-15.12%-33.4B
-0.86%-141.67B
29.98%-9.73B
13.83%-38.58B
-32.21%-64.34B
12.40%-29.01B
-13.84%-140.46B
73.14%-13.9B
Non-operating interest income
1,357.46%87.87B
978.62%44.4B
140.43%73.76B
73.90%19.64B
76.54%-8.17B
-132.07%-6.99B
-56.02%4.12B
15.96%30.68B
105.03%11.29B
29.85%-34.81B
Non-operating interest expense
291.27%123.63B
21.45%83.14B
79.52%107.16B
14.87%137.31B
57.78%-22.43B
-52.54%31.6B
17.98%68.45B
0.19%59.69B
2.19%119.54B
-442.57%-53.13B
Total other finance cost
----
----
----
-25.53%24B
----
----
----
----
170.31%32.22B
----
Other net income /expenses
140.93%799M
-288.60%-2.08B
24.72%-536M
2.08%-169.31B
5.43%-166.11B
-101.17%-1.95B
-126.42%-535M
-70.33%-712M
-93.55%-172.91B
-103.75%-175.64B
Gain on sale of security
----
----
----
183.25%7.6B
----
----
----
----
-241.82%-9.13B
----
Special income /charges
----
----
----
-1.57%-172.92B
----
----
----
----
-55.39%-170.25B
----
-Less:Restructuring and mergern&acquisition
----
----
----
24.89%127.53B
----
----
----
----
61.51%102.12B
----
-Less:Other special charges
----
----
----
-40.72%37.57B
----
----
----
----
157.52%63.37B
----
-Less:Write off
----
----
----
44.34%18.38B
----
----
----
----
-58.42%12.74B
----
-Gain on sale of business
----
----
----
30.23%10.2B
----
----
----
----
15.04%7.83B
----
-Gain on sale of property,plant,equipment
----
----
----
152.08%363M
----
----
----
----
-93.12%144M
----
Income before tax
406.93%133.86B
-76.40%28.17B
10.27%150.63B
231.66%175.08B
-125.79%-107.3B
-56.89%26.41B
224.37%119.37B
1.16%136.6B
-85.93%52.79B
-199.18%-47.52B
Income tax
1,071.50%30.13B
46.35%39.9B
-36.20%26.35B
173.23%66.94B
90.57%-4.2B
105.78%2.57B
156.79%27.27B
-9.47%41.3B
-257.46%-91.41B
-365.38%-44.53B
Net income
335.21%103.73B
-112.73%-11.73B
30.41%124.28B
-25.00%108.14B
-3,343.49%-103.1B
-77.46%23.84B
292.01%92.11B
6.59%95.3B
-54.52%144.2B
-109.62%-2.99B
Net income continuous operations
335.21%103.73B
-112.73%-11.73B
30.41%124.28B
-25.00%108.14B
-3,343.49%-103.1B
-77.46%23.84B
292.00%92.11B
6.59%95.3B
-54.52%144.2B
-109.62%-2.99B
Noncontrolling interests
104.35%94M
18.03%72M
-29.41%36M
65.38%215M
137.50%57M
31.43%46M
3.39%61M
363.64%51M
519.05%130M
1,100.00%24M
Net income attributable to the company
335.66%103.64B
-112.82%-11.8B
30.44%124.24B
-25.08%107.93B
-3,317.99%-103.16B
-77.50%23.79B
291.64%92.05B
6.55%95.25B
-54.56%144.07B
-109.69%-3.02B
Net income attributable to common stockholders
335.66%103.64B
-112.82%-11.8B
30.44%124.24B
-25.08%107.93B
-3,317.99%-103.16B
-77.50%23.79B
291.64%92.05B
6.55%95.25B
-54.56%144.07B
-109.69%-3.02B
Diluted earnings per share
342.40%65.74
-113.47%-7.83
30.79%79.4
-25.77%68.36
-3,151.24%-65.35
-78.01%14.86
289.50%58.14
5.56%60.71
-54.92%92.09
-110.07%-2.01
Basic earnings per share
343.62%64.68
-113.70%-7.83
30.51%78.23
-26.25%67.23
-3,151.24%-65.35
-78.20%14.58
286.34%57.17
4.94%59.94
-54.86%91.16
-110.42%-2.01
Dividend per share
--0
2.04%100
--0
4.26%196
4.26%98
--0
4.26%98
--0
4.44%188
4.44%94
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Dec 31, 2025(Q2)Sep 30, 2025(Q1)Jun 30, 2025(FY)Mar 31, 2025(Q4)Mar 31, 2025(Q3)Dec 31, 2024(Q2)Sep 30, 2024(Q1)Jun 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024
Total revenue 4.16%1.19T-5.38%1.11T-8.39%1.11T7.45%4.58T0.24%1.05T2.96%1.14T12.75%1.18T14.11%1.21T5.87%4.26T9.91%1.05T
Operating revenue 4.16%1.19T-5.38%1.11T-8.39%1.11T7.45%4.58T0.24%1.05T2.96%1.14T12.75%1.18T14.11%1.21T5.87%4.26T9.91%1.05T
Cost of revenue -3.77%401.15B-3.61%380.06B-0.59%384.68B10.76%1.58T-0.11%382.08B9.85%416.87B14.76%394.31B20.50%386.95B14.68%1.43T23.48%382.5B
Gross profit 8.70%790.55B-6.27%732.74B-12.06%722.01B5.79%3T0.44%671.32B-0.61%727.25B11.75%781.73B11.33%821.04B1.93%2.84T3.40%668.37B
Operating expense -5.84%621.73B11.09%663.74B-17.91%537.45B1.80%2.52T14.52%602.78B-16.71%660.31B-20.21%597.48B15.08%654.71B12.54%2.47T14.30%526.35B
Selling and administrative expenses 4.51%282.78B-5.49%253.55B-5.24%255.89B4.83%1.1T3.73%295.87B1.15%270.59B6.06%268.28B8.83%270.03B5.67%1.05T11.95%285.23B
Research and development costs 2.96%175.23B-8.02%161.48B-14.59%143.89B0.04%730.23B10.29%216.01B-9.17%170.19B-4.56%175.56B3.52%168.46B15.25%729.92B21.69%195.86B
Depreciation amortization depletion 5.19%141.91B44.06%205.16B-19.16%131.64B-1.36%643.23B39.94%203.08B-46.69%134.91B-40.72%142.41B25.81%162.83B20.22%652.12B8.92%145.11B
-Depreciation and amortization 5.19%141.91B44.06%205.16B-19.16%131.64B-1.36%643.23B39.94%203.08B-46.69%134.91B-40.72%142.41B25.81%162.83B20.22%652.12B8.92%145.11B
Other operating expenses -74.24%21.8B288.16%43.55B-88.70%6.03B5.67%37.05B-12.33%-112.17B-0.22%84.61B-84.35%11.22B86.29%53.38B55.70%35.06B-12.90%-99.86B
Operating profit 152.19%168.82B-62.55%69B10.96%184.57B32.74%486.06B-51.74%68.54B209.60%66.94B473.41%184.25B-1.33%166.33B-37.71%366.17B-23.59%142.02B
Net non-operating interest income /expenses 7.33%-35.76B39.78%-38.74B-15.12%-33.4B-0.86%-141.67B29.98%-9.73B13.83%-38.58B-32.21%-64.34B12.40%-29.01B-13.84%-140.46B73.14%-13.9B
Non-operating interest income 1,357.46%87.87B978.62%44.4B140.43%73.76B73.90%19.64B76.54%-8.17B-132.07%-6.99B-56.02%4.12B15.96%30.68B105.03%11.29B29.85%-34.81B
Non-operating interest expense 291.27%123.63B21.45%83.14B79.52%107.16B14.87%137.31B57.78%-22.43B-52.54%31.6B17.98%68.45B0.19%59.69B2.19%119.54B-442.57%-53.13B
Total other finance cost -------------25.53%24B----------------170.31%32.22B----
Other net income /expenses 140.93%799M-288.60%-2.08B24.72%-536M2.08%-169.31B5.43%-166.11B-101.17%-1.95B-126.42%-535M-70.33%-712M-93.55%-172.91B-103.75%-175.64B
Gain on sale of security ------------183.25%7.6B-----------------241.82%-9.13B----
Special income /charges -------------1.57%-172.92B-----------------55.39%-170.25B----
-Less:Restructuring and mergern&acquisition ------------24.89%127.53B----------------61.51%102.12B----
-Less:Other special charges -------------40.72%37.57B----------------157.52%63.37B----
-Less:Write off ------------44.34%18.38B-----------------58.42%12.74B----
-Gain on sale of business ------------30.23%10.2B----------------15.04%7.83B----
-Gain on sale of property,plant,equipment ------------152.08%363M-----------------93.12%144M----
Income before tax 406.93%133.86B-76.40%28.17B10.27%150.63B231.66%175.08B-125.79%-107.3B-56.89%26.41B224.37%119.37B1.16%136.6B-85.93%52.79B-199.18%-47.52B
Income tax 1,071.50%30.13B46.35%39.9B-36.20%26.35B173.23%66.94B90.57%-4.2B105.78%2.57B156.79%27.27B-9.47%41.3B-257.46%-91.41B-365.38%-44.53B
Net income 335.21%103.73B-112.73%-11.73B30.41%124.28B-25.00%108.14B-3,343.49%-103.1B-77.46%23.84B292.01%92.11B6.59%95.3B-54.52%144.2B-109.62%-2.99B
Net income continuous operations 335.21%103.73B-112.73%-11.73B30.41%124.28B-25.00%108.14B-3,343.49%-103.1B-77.46%23.84B292.00%92.11B6.59%95.3B-54.52%144.2B-109.62%-2.99B
Noncontrolling interests 104.35%94M18.03%72M-29.41%36M65.38%215M137.50%57M31.43%46M3.39%61M363.64%51M519.05%130M1,100.00%24M
Net income attributable to the company 335.66%103.64B-112.82%-11.8B30.44%124.24B-25.08%107.93B-3,317.99%-103.16B-77.50%23.79B291.64%92.05B6.55%95.25B-54.56%144.07B-109.69%-3.02B
Net income attributable to common stockholders 335.66%103.64B-112.82%-11.8B30.44%124.24B-25.08%107.93B-3,317.99%-103.16B-77.50%23.79B291.64%92.05B6.55%95.25B-54.56%144.07B-109.69%-3.02B
Diluted earnings per share 342.40%65.74-113.47%-7.8330.79%79.4-25.77%68.36-3,151.24%-65.35-78.01%14.86289.50%58.145.56%60.71-54.92%92.09-110.07%-2.01
Basic earnings per share 343.62%64.68-113.70%-7.8330.51%78.23-26.25%67.23-3,151.24%-65.35-78.20%14.58286.34%57.174.94%59.94-54.86%91.16-110.42%-2.01
Dividend per share --02.04%100--04.26%1964.26%98--04.26%98--04.44%1884.44%94
Currency Unit JPYJPYJPYJPYJPYJPYJPYJPYJPYJPY
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--
Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +8.45%
Sample Name
Sample Code
 +4.80%
Sample Name
Sample Code
 +3.86%
4
CNOOC
00883
+3.77%
5
SINOPEC CORP
00386
+2.61%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +61.02%
Sample Name
Sample Code
 +51.07%
Sample Name
Sample Code
 +40.94%
4
Business-intelligence Of Oriental Nations Corporation
300166
+33.12%
5
Emdoor Information
001314
+32.98%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to the latest report from AXIOS, the US expects Iran to respond on several key issues within the next 48 hours. No agreement has b Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -